Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kuhuang (苦黄) is a traditional Chinese medicine formulation used primarily for the treatment of liver-related conditions such as cholestatic jaundice and viral hepatitis. It is available in both granule and injectable forms. Clinical studies have explored its efficacy in improving symptoms of cholestatic jaundice and viral hepatitis by supporting liver function and reducing bilirubin levels[1][2]. The mechanism of action is not fully elucidated but is believed to involve hepatoprotective effects through anti-inflammatory and antioxidative pathways typical of many TCM herbal formulations. Kuhuang is developed within the framework of traditional Chinese medicine rather than by a single pharmaceutical company.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kuhuang.